SCHEMBL7082286

SCHEMBL7082286

Cc1c(C(=O)CC(=O)c2cc(Cn3cncn3)ccn2)cc(-n2cccn2)cc1-n1cccn1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
KLKB1 P03952 5/20 0.35
PI4KB Q9UBF8 1/20 0.34
KAT6A Q92794 1/20 0.34
FLT1 P17948 1/20 0.34
KDR P35968 1/20 0.34
CYP19A1 P11511 3/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTPN5 P54829 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
GSK3B P49841 1/20 0.33
LMNA P02545 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078633 0.82 KMT2A (0.43) PI4KBKAT6AJAK2JAK3LMNA
SCHEMBL7079537 0.79 CTNNB1 (0.41) PI4KBKAT6AJAK2JAK3LMNA
SCHEMBL7082284 0.76 HDAC1 (0.48) HDAC1HDAC6KLKB1FLT1KDR
SCHEMBL7077224 0.75 KLKB1 (0.35) KLKB1PI4KBKAT6AJAK2JAK3
SCHEMBL7077265 0.74 KAT6A (0.39) PI4KBKAT6AJAK2JAK3LMNA
SCHEMBL7081867 0.73 HCRTR1 (0.40) PI4KBKAT6AJAK2JAK3LMNA
SCHEMBL7078767 0.72 HDAC1 (0.43) HDAC1HDAC6KLKB1CYP19A1ALOX15
SCHEMBL7077756 0.70 F2RL1 (0.38) PI4KBKAT6AJAK2JAK3LMNA
SCHEMBL7077761 0.70 HDAC1 (0.49) HDAC1HDAC6FLT1KDRCYP19A1
SCHEMBL7078642 0.69 HDAC1 (0.55) HDAC1HDAC6FLT1KDRCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US claimed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP claimed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP claimed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO claimed
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP disclosed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP disclosed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 HDAC1 731/4885HDAC6 4113/4885KLKB1 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.